Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010
José A. Karam(The University of Texas MD Anderson Cancer Center), Viraj A. Master(Emory University), Mahrukh Huseni(Gene Therapy Laboratory), Axel Bex(The Royal Free Hospital), Sumanta Kumar Pal(City of Hope), Alexander Andreev-Drakhlin(Broad Institute), William Leung, Connie Tat, Alan Nicholas, Robert G. Uzzo(American Urological Association)
Cited by 4
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k